OPTION CARE HEALTH INC (OPCH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for OPCH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OPCH | Independent Director | 58 | ["Interim Chief Financial Officer of DENTSPLY Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President, Finance, of Mallinckrodt plc","Vice President, Global Commercial Finance of Hospira","Positions of increasing responsibility at Eli Lilly & Company","Extensive finance, accounting, and risk management experience","Significant healthcare industry experience","Experience with corporate governance matters, risk management, and management oversight"] | ["Audit and Finance Committee","Compensation Committee","Audit and Finance","Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMRN | Director, Enovis Corp. | 58 | ["Director, Option Care Health, Inc.","extensive experience serving on the boards of biotechnology and pharmaceutical organizations","financial and accounting expertise","interim Chief Financial Officer of Dentsply Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President of Finance of Mallinckrodt Pharmaceuticals","senior finance roles at Hospira, Inc. and Eli Lilly and Company","holds a B.S. in Finance","M.B.A from Indiana University"] | [] | 2026 |
| ENOV | Former Chief Financial Officer; Director | 58 | ["Former Chief Financial Officer, Hill-Rom Holdings, Inc.","Extensive finance, accounting and risk management experience, including as a public company chief financial officer","Significant medical device and healthcare industry experience","Board leadership experience as an audit committee member and chair, nom/gov committee member and compensation committee member"] | ["Audit"] | 2026 |
Biography sourced from the proxy statement filing.
Independent Director Since: 2024 Age: 58 Committees: Audit and Finance Nominating and Corporate Governance Experience Interim Chief Financial Officer of DENTSPLY Sirona Inc., a publicly-traded manufacturer of professional dental products and technologies (May 2022-October 2022) Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc., a medical device and technology provider (2018-2021) Senior Vice President, Finance, of Mallinckrodt plc, a global specialty pharmaceutical company (2015-2018) Vice President, Global Commercial Finance of Hospira, a global pharmaceutical and medical device company (2013-2015) Positions of increasing responsibility at Eli Lilly & Company, a global pharmaceutical company (1997-2013) Key Skills and Qualifications Extensive finance, accounting, and risk management experience, including through her service as a public company chief financial officer Significant healthcare industry experience gained through her service at numerous large, complex healthcare organizations Her service on numerous public company boards of directors, including as an audit committee member and chair, provides experience with corporate governance matters, risk management, and management oversight Other U.S. Public Company Boards BioMarin Pharmaceutical Inc. (2023-Present) Enovis Corporation (2022-Present) Former U.S. Public Company Boards (within last five years) Syneos Health, Inc. Turning Point Therapeutics, Inc.